Citation only
via OpenAlex
Targeting cellular senescence with senotherapeutics: senolytics and senomorphics
Lei Justan Zhang, Louise E. Pitcher, Vaishali Prahalad, Laura J. Niedernhofer, Paul D. Robbins
FEBS Journal · 2022 · ▲ 648 citations
Abstract
The concept of geroscience is that since ageing is the greatest risk factor for many diseases and conditions, targeting the ageing process itself will have the greatest impact on human health. Of the hallmarks of ageing, cellular senescence(definition) has emerged as a druggable therapeutic target for extending healthspan(definition) in model organisms. Cellular senescence is a cell state of irreversible proliferative arrest driven by different types of stress, including oncogene-induced stress. Many senescent cells (SnCs) develop a senescent-associated secretory phenotype (SASP) comprising pro-inflammatory cytokines, chemokines, proteases, bioactive lipids, inhibitory molecules, extracellular vesicles, metabolites, lipids and other factors, able to promote chronic inflammation and tissue dysfunction. SnCs up-regulate senescent cell anti-apoptotic pathways (SCAPs) that prevent them from dying despite the accumulation of damage to DNA and other organelles. These SCAPs and other pathways altered in SnCs represent therapeutic targets for the development of senotherapeutic drugs that induce selective cell death of SnCs, specifically termed senolytics(definition) or suppress markers of senescence, in particular the SASP, termed senomorphics. Here, we review the current state of the development of senolytics and senomorphics for the treatment of age-related diseases and disorders and extension of healthy longevity. In addition, the challenges of documenting senolytic and senomorphic activity in pre-clinical models and the current state of the clinical application of the different senotherapeutics will be discussed.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/febs.16350
- Canonical
- link ↗
- Fetched
- 2026-11-06 MST
Cite this
APA
Zhang, L.J., Pitcher, L.E., Prahalad, V., Niedernhofer, L.J., & Robbins, P.D. (2022). Targeting cellular senescence with senotherapeutics: senolytics and senomorphics. <em>FEBS Journal</em>. https://doi.org/10.1111/febs.16350
Vancouver
Zhang LJ, Pitcher LE, Prahalad V, Niedernhofer LJ, Robbins PD. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics. FEBS Journal. 2022. doi:10.1111/febs.16350.
BibTeX
@article{lei2022Target,
title = {Targeting cellular senescence with senotherapeutics: senolytics and senomorphics},
author = {Lei Justan Zhang and Louise E. Pitcher and Vaishali Prahalad and Laura J. Niedernhofer and Paul D. Robbins},
journal = {FEBS Journal},
year = {2022},
doi = {10.1111/febs.16350},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Annals of Rejuvenation Science 2026
Open access · CC-BY
Cellular Senescence
Genetics and Molecular Research 2026
Open access · CC-BY
CELLULAR SENESCENCE: MOLECULAR MECHANISMS AND SENOLYTIC AND SENOMORPHIC STRATEGIES
Biomolecules 2025
Open access · CC-BY
Targeting Senescence: A Review of Senolytics and Senomorphics in Anti-Aging Interventions
International Journal of Veterinary Sciences and Animal Husbandry 2026
Open access · OA
Senotherapeutics: emerging pharmacological strategies for targeting cellular senescence
Cardiovascular Research 2021
Open access · OA
Senescence mechanisms and targets in the heart
Frontiers in Life Sciences Research 2026
Open access · OA